| First Author | Foubert P | Year | 2017 |
| Journal | Cancer Immunol Res | Volume | 5 |
| Issue | 11 | Pages | 957-968 |
| PubMed ID | 28963139 | Mgi Jnum | J:318443 |
| Mgi Id | MGI:6859691 | Doi | 10.1158/2326-6066.CIR-17-0143 |
| Citation | Foubert P, et al. (2017) PI3Kgamma Activates Integrin alpha4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression. Cancer Immunol Res 5(11):957-968 |
| abstractText | Immunosuppressive myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) accumulate in tumors where they inhibit T cell-mediated antitumor immune responses and promote tumor progression. Myeloid cell PI3Kgamma plays a role in regulating tumor immune suppression by promoting integrin alpha4-dependent MDSC recruitment to tumors and by stimulating the immunosuppressive polarization of MDSCs and TAMs. Here, we show that integrin alpha4 promotes immunosuppressive polarization of MDSCs and TAMs downstream of PI3Kgamma, thereby inhibiting antitumor immunity. Genetic or pharmacological suppression of either PI3Kgamma or integrin alpha4 blocked MDSC recruitment to tumors and also inhibited immune suppressive myeloid cell polarization, thereby reducing expression of IL10 and increasing expression of IL12 and IFNgamma within tumors. Inhibition of PI3Kgamma or integrin alpha4 within tumors stimulated dendritic cell and CD8(+) T-cell recruitment and maturation, as well as tumor cell cytotoxicity in vivo, thereby inhibiting tumor growth. As blockade of PI3Kgamma or integrin alpha4 prevents accumulation of MDSC and reduces myeloid cell expression of immunosuppressive factors that stimulate tumor immune escape, these results highlight PI3Kgamma and integrin alpha4 as targets for the design of cancer therapeutics. Cancer Immunol Res; 5(11); 957-68. (c)2017 AACR. |
